跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Candesaph-16 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Candesaph-16
Approved
STANDARD
Candesaph-16
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9e0c4ec74cbd1101
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
9e0c4ec74cbd1101
Drug Approval Philippines Name
Candesaph-16
Product Name
Candesaph-16
Registration Number
DRP-11552
Brand Name
Candesaph-16
Generic Name
Candesartan Cilexetil
Dosage Form
Tablet
Dosage Strength
16mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
29 March 2022
Expiry Date
29 March 2027
Pharmacologic Category
Angiotensin-II-Receptor Blocker (ARB)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9e0c4ec74cbd1101
Type
Standard
Back to Philippines FDA Approvals